No results found for “”
No results found for filter “”
-
EFPIA News 25.09.17
EFPIA Vacancy: Manager, Scientific, Regulatory & Manufacturing team
The Manager Scientific, Regulatory & Manufacturing – ICH (SRM-ICH) coordinates and leads the work on allocated topics and tasks related to scientific,...
Read Article -
Blog articles 21.09.17
Disease interception – What does it mean and why is it important? (Guest blog)
As our scientific understanding increases, catching diseases earlier is becoming more and more likely. For many conditions, early treatment offers the...
Read Article -
Blog articles 21.09.17
ISENTRESS: integrase strand transfer inhibitor active against HIV type 1
With over 7000 medicines in development, new treatments will continue to change patients’ lives; slowing disease progression, avoiding illness and reducing...
Read Article -
Blog articles 07.09.17
EFPIA’s Rentrée 2017: Unlocking tomorrow’s cures
EFPIA brought together leading scientists at the cutting edge of medicines development to the Brussels healthcare-policy world
Read Article -
Blog articles 31.08.17
EU legislation and science further the protection of laboratory animals
EFPIA’s goals are to accelerate the development of and access to integrated healthcare solutions for unmet medical needs in the interests of patients and...
Read Article -
Blog articles 25.08.17
The Future of Patient-Centered Oncology Care in Europe
This week sees cancer experts from all over the world descend on Madrid for ESMO2017, the European Society of Medical Oncology’s annual congress.
Read Article -
Statements & press releases 27.07.17
EFPIA statement on BMJ study on company policies for clinical trials transparency
EFPIA and its member companies believe that sharing clinical trial data is in the best interests of patients, clinicians, medical research and the pharmaceutical...
Read Article -
Statements & press releases 20.07.17
Early, transparent dialogue between regulators and the companies developing new medicines is in the best...
EFPIA notes the EU Ombudsman's decision to conduct a strategic inquiry into the arrangements that the EMA has in place for engaging with individual medicines...
Read Article -
Blog articles 20.07.17
Building the European health data eco-system
The societal benefits of creating a more connected and sustainable health data eco-system in Europe are too big an opportunity to be ignored
Read Article -
Statements & press releases 13.07.17
Joint trade association letter on Brexit
A joint letter to underline the importance of securing ongoing cooperation between the UK and EU on medicines
Read Article -
Blog articles 12.07.17
Real leadership and innovation starts by looking beyond the edge (Guest blog)
A guest blog by Paul-Peter Tak, Senior Vice President (SVP) R&D Pipeline, Chair of the Development Steering Team and Chief Immunology Officer at GSK
Read Article -
Blog articles 11.07.17
Collaboration in cancer research (Guest blog)
International Immuno-Oncology Network boosts understanding of tumor biology to improve patient outcomes
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 25.09.17
EFPIA Vacancy: Manager, Scientific, Regulatory & Manufacturing team
The Manager Scientific, Regulatory & Manufacturing – ICH (SRM-ICH) coordinates and leads the work on allocated topics and tasks related to scientific,...
Read Article -
EFPIA News 10.07.17
Vacancy: EFPIA Director Intellectual Property Policy
The Director Intellectual Property Policy ensures that EFPIA's IP policy activities are focused on progressing and delivering the relevant EFPIA priorities....
Read Article -
EFPIA News 03.07.17
EFPIA-College of Europe Prize
The 2017 Laureat of the EFPIA-College of Europe Prize is Luca Deplano
Read Article -
EFPIA News 30.05.17
Final Call ATMP Survey
Help improve product development and regulation
Read Article -
EFPIA News 24.04.17
Open Letter from the Pharmaceutical Industry Heads of Research and EFPIA on the Relocation of the European...
Read Article -
EFPIA News 19.04.17
EPAA Refinement Prize 2017
Call for Submissions
Read Article -
EFPIA News 31.03.17
Open Invitation for ATMP-developers
To help improve product development and its regulation
Read Article -
EFPIA News 01.03.17
New project: success and failure in the development and commercialisation of ATMP products
A Lygature’s project
Read Article -
EFPIA News 20.02.17
Joint Declaration on EU Industrial Strategy
Read Article -
EFPIA News 15.12.16
EFPIA opinion on Health at a Glance: Europe 2016
Read Article -
EFPIA News 17.11.16
EFPIA Health Collaboration Summit 2016 Summary Report
Read Article -
EFPIA News 10.11.16
Health Collaboration Summit 2016
A summary of the first day
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 27.07.17
EFPIA statement on BMJ study on company policies for clinical trials transparency
EFPIA and its member companies believe that sharing clinical trial data is in the best interests of patients, clinicians, medical research and the pharmaceutical...
Read Article -
Statements & press releases 20.07.17
Early, transparent dialogue between regulators and the companies developing new medicines is in the best...
EFPIA notes the EU Ombudsman's decision to conduct a strategic inquiry into the arrangements that the EMA has in place for engaging with individual medicines...
Read Article -
Statements & press releases 13.07.17
Joint trade association letter on Brexit
A joint letter to underline the importance of securing ongoing cooperation between the UK and EU on medicines
Read Article -
Statements & press releases 30.06.17
Meeting with Heads of Agencies/High level representatives and Heads of Europe of Pharmaceutical Companies...
European stakeholders of Health Technology Assessments came together to discuss important new developments for further cooperation
Read Article -
Statements & press releases 29.06.17
EFPIA, EBE and Vaccines Europe Back EU Leadership in Sustainable, Collaborative Fight Against AMR
The launch of the European Commission’s Action Plan on Antimicrobial Resistance (AMR) confirms the EU’s determination to take a leading role in combatting...
Read Article -
Statements & press releases 23.06.17
EFPIA Expresses Concern at Postponement of Resolution on EMA Relocation
As talks begin in earnest on the United Kingdom’s departure from the EU, EFPIA expresses its concern that the Heads of State yesterday decided to postpone...
Read Article -
Statements & press releases 20.06.17
Pharmaceutical companies continue to drive transparency and underline industry investment in Europe’s...
Over the next ten days, pharmaceutical companies will disclose details of collaborations with health professionals (HCPs) and healthcare organisations...
Read Article -
Statements & press releases 20.06.17
EFPIA Appoints New President and Vice Presidents
EFPIA is delighted to announce the appointment of three key roles on the EFPIA Board
Read Article -
Statements & press releases 14.06.17
EFPIA: unlocking tomorrow’s cures
Read Article -
Statements & press releases 07.06.17
An Ambitious FP9 Strengthening Europe’s Industrial Leadership
Joint Declaration by Industry and RTOs
Read Article -
Statements & press releases 17.05.17
EFPIA/CPIA Workshop to Scrutinise a Variety of Regulatory and Legal Issues
The fourth EFPIA/CPIA joint China/EU Pharmaceutical Industry Forum Workshop takes place on 17 May 2017
Read Article -
Statements & press releases 05.05.17
Industry Welcomes the 3rd European Commission Workshop on Biosimilar Medicines
EFPIA, EuropaBio and Medicines for Europe, welcome both efforts to further promote the exchange of neutral information and learnings on biosimilars between...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 21.09.17
Disease interception – What does it mean and why is it important? (Guest blog)
As our scientific understanding increases, catching diseases earlier is becoming more and more likely. For many conditions, early treatment offers the...
Read Article -
Blog articles 21.09.17
ISENTRESS: integrase strand transfer inhibitor active against HIV type 1
With over 7000 medicines in development, new treatments will continue to change patients’ lives; slowing disease progression, avoiding illness and reducing...
Read Article -
Blog articles 07.09.17
EFPIA’s Rentrée 2017: Unlocking tomorrow’s cures
EFPIA brought together leading scientists at the cutting edge of medicines development to the Brussels healthcare-policy world
Read Article -
Blog articles 31.08.17
EU legislation and science further the protection of laboratory animals
EFPIA’s goals are to accelerate the development of and access to integrated healthcare solutions for unmet medical needs in the interests of patients and...
Read Article -
Blog articles 25.08.17
The Future of Patient-Centered Oncology Care in Europe
This week sees cancer experts from all over the world descend on Madrid for ESMO2017, the European Society of Medical Oncology’s annual congress.
Read Article -
Blog articles 20.07.17
Building the European health data eco-system
The societal benefits of creating a more connected and sustainable health data eco-system in Europe are too big an opportunity to be ignored
Read Article -
Blog articles 12.07.17
Real leadership and innovation starts by looking beyond the edge (Guest blog)
A guest blog by Paul-Peter Tak, Senior Vice President (SVP) R&D Pipeline, Chair of the Development Steering Team and Chief Immunology Officer at GSK
Read Article -
Blog articles 11.07.17
Collaboration in cancer research (Guest blog)
International Immuno-Oncology Network boosts understanding of tumor biology to improve patient outcomes
Read Article -
Blog articles 06.07.17
Patients Must Be Central in Any Decision on the EMA’s New Home
From an industry perspective, securing cooperation on the regulation of medicines for patients and public health as part of the negotiations will be key...
Read Article -
Blog articles 30.06.17
Diagnostics to save lives (Guest blog)
Read Article -
Blog articles 19.06.17
What lies ahead for the pharmaceutical sector in France?
Read Article -
Blog articles 14.06.17
The Patient Organization Academy (Guest blog)
Read Article